6.Cardiovascular Supporting Drugs
description
Transcript of 6.Cardiovascular Supporting Drugs
![Page 1: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/1.jpg)
EMERGENCY SUPPORTING
DRUGS
SMF/BAG. ANESTESIOLOGI & REANIMASIRSUD dr. MOEWARDI/FK UNS
![Page 2: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/2.jpg)
These drugs have the advantages in increasing on cerebral and
coronary perfusion. It also usefull to control rate and rhythm of the
heart. We administer these drugs before, during and
after CPR
![Page 3: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/3.jpg)
IMPORTANT DRUGS• BP
- Epinephrine / adrenaline- Vasopresine- Dopamine
• HR- Atropine
• Ventricular arrhythmia- Amiodarone - Procainamide- Lidocaine - MgSO4
![Page 4: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/4.jpg)
• Supraventriculare arrhythmia
- Adenosine- Diltiazem- Amiodarone
• AMI- Morphine - Aspirine- Nitroglycerine - Fibrinolytica
• MISC- Sodium bicarbonate- Calcium chloride
![Page 5: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/5.jpg)
DECISION TO USE AGENT
1. Understand mechanism of action
2. Know indication for use3. Know advert effect4. Know potential interactions
![Page 6: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/6.jpg)
EPINEPHRINE/ADRENALINE
MECHANISM OF ACTION- & adrenergic stimulation- SVR, BP (S & D)- coronary and cerebral blood flow- myocardial O2 requirement- electrical & strength of myocardium- automaticity
![Page 7: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/7.jpg)
INDICATION - All patients in cardiac arrest- Severe hypotention- Symptomatic bradycardia- Anaphylaxis
![Page 8: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/8.jpg)
DOSAGEa. Cardiac arrest :
1 mg I.V. flush with 20 ml NS + arm
elevation for 10-20 s 2 – 2,5 x i.v. dose through ETT
b. Non cardiac arrest : 2 – 20 mc/min
PRECAUTIONS- Precipitable in alkaline solution
![Page 9: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/9.jpg)
VASOPRESSIN
MECHANISM OF ACTION- Potent vasoconstrictor- SVR, BP (S&D)- Coronary and cerebral blood flow
INDICATION- alternative to 1st and 2nd dose of epinephrine for VF / VT (-)
![Page 10: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/10.jpg)
DOSAGE40 I.V. Push 1x
PRE CAUTIONmay provoke cardiac ischemia
![Page 11: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/11.jpg)
MECHANISM OF ACTION :stimulation of dopaminergie & adrenergic receptor
INDICATION- Hipotension (70 – 100 mmHg)- Second drug for hypotensive
bradycardia
DOPAMINE
![Page 12: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/12.jpg)
DOSAGE :- 5 – 20 mc/Kg/min- titrate to response
PRECAUTIONS :- Start after volume replacement- tapper gradually- do not mix with sodium bicarbonate- monitor I.V. site
![Page 13: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/13.jpg)
MECHANISME OF ACTION - Block parasympathetic receptor of heart - SA node automatically - AV node conduction - Not to stimulate the hear
INDICATION - Symptomatic sinus bradycardia- While waiting for pacing- Second drug in asystole / PEA- Organophosphate poisoning
ATROPINE
![Page 14: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/14.jpg)
DOSAGE- Arrest : 1 mg i.v. 2 - 3 mg ETT- Bradycardia : 0,5 mg i.v- Max 3 mg- Extremely large doses may be need for organophospate poisoning
PRECAUTIONS- paradoxical bradycardia with < 0,5 mg- worsen myocardial ischaemia- avoid in hypothermia bradycardia- not useful in AV block of : 2nd degree type II 3rd degree
![Page 15: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/15.jpg)
AGENT FOR CONTROL OF RATE AND RHYTHMClassification of antiarrhythm
Vw CLASS CHANNEL EFFECT EFFECT ON ACTION POTENTIAL
DRUG
1a Na channel blockersmoderate
Phase 0Na influx
ProcainamideDisopyramide
1b Na channel blockersWeak
Phase 0Na influx
lidocain
1c Na channel blockersstrong
Phase 0Na influx
PropafenonFlecainamide
II adrenergic blockers Decreased SA node automaticitySlow av node conduction
Atenolol,Propanolol,metoprolol,esmolol,labetolol
III K channel blockers Phase 3K efflux
Amiodaron,bretilium,dofetilide,ibutilide,sotaol
IV ca channel blockers Phase 4Ca influx
Diltiazem,verapamil
![Page 16: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/16.jpg)
AMIODARONE
MECHANISME OF ACTION- block Na, K and Ca channels- and blocking properties
INDICATION- VF/ VT cardiac arrest refractory to shock + epinephrine- Recurrent life – threatening VT- Other arrhythmias- VT narrow QRS
![Page 17: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/17.jpg)
DOSAGE- Cardiac arrest 300 mg i.v. push (in 20 ml D5) + 150 mg i.v. push in 3 – 5 min 1x
- Ventricular tachyarrhythmias 150 mg i.v. over 10 min
- Maintenance 1 mg/min i.v. for 6 hours then 0,5 mg/min i.v. for 18 hours
- Max dose 2,2 g/day
![Page 18: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/18.jpg)
PRECAUTIONS- Multiple drugs interaction- Long half-life (up to 40 days)- Hypotention with rapid/repeated dose- Prolong QT interval
![Page 19: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/19.jpg)
LIDOCAINE / LIGNOCAINE
• MECHANISM OF ACTION- block Na channel- ventricular ectopy- excitability in ischemic tissue
• INDICATION - alternative to amiodarone in cardiac arrest for VT/VF - stable VT with good LV
![Page 20: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/20.jpg)
• DOSAGE
- Loading : 1 - 1,5 mg/Kg i.v. push (arrest) 0,5 – 0,75 mg/Kg i.v. push (stable VT) ETT = 2 – 4 mg/Kg
- Maintenance :
1– 4 mg/min i.v.
![Page 21: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/21.jpg)
- Precautions Not reccomended as prophylaxis in MI Reduce dose
- Impaired liver function - Poor LV
Stop infusion if sign of toxicity occurs
![Page 22: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/22.jpg)
PROCAINAMIDE
MECHANISME OF ACTION :- block Na channel- ventricular ectopy- conduction
INDICATION :- suppression of recurrent VT/VF- other tachy-arrhythmias
![Page 23: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/23.jpg)
DOSAGE :Reccurrent VT/VF :- 20 mg/min- maintenance = 1 – 4 mg/min
PRECAUTIONS :- hypotension- reduce to 12 mg/min in patient with heart/renal failure - prolong QT interval- pro-arrhythmic, esp. in AMI, K, Mg
![Page 24: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/24.jpg)
MAGNESIUM SULPHATE• Drug of choice for Torsades de
pointes
• Dosage :- 1 – 2 gr i.v. over 5 – 20 min- then infusion 0,5 – 1 gr/hr- Titrate to control Torsades
![Page 25: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/25.jpg)
ADENOSINE/AT
P• MECHANISME OF ACTION :
- SA node and AV node- short half life < 5 s
• INDICATION :- termination of PSVT- unstable SVT during cardioversion preparation - will be difficult to indentify SVT with narrow QRS
![Page 26: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/26.jpg)
• DOSAGE :- 6 mg adenosine/10 mg ATP push 1 – 3 s follow by 20 ml NS if no response in 1 – 2 min- 12 mg adenosine/20 mg ATP push- 3rd dose of 12 mg adenosine/20 mg ATP
• PRECAUTIONS :flushing, dyspnoe, chest pain
![Page 27: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/27.jpg)
DILTIAZEM
• MECHANISME OF ACTION :- Ca channel blocker- automaticity- conduction
• INDICATION :- rate control for AF- terminate stable re-entry SVT if adenosine fails
![Page 28: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/28.jpg)
• DOSAGE :- 15 – 20 mg over 2 min- repeat in 15 min at 20 - 25 mg i.v.- then 5 – 15 mg/hr- titrate of effect
»PRECAUTIONS :Not to be used in :- wide complex tachycardia of uncertain origin- drug induced tachycardia- WPW syndrome with AF
![Page 29: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/29.jpg)
DRUGS FOR AMI
greets all MI patients
![Page 30: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/30.jpg)
MORPHINE
• MECHANISME OF ACTION :- relieve pain and anxiety- myocardial oxygen demand- SVR- venous capacitance
• INDICATION :- chest pain- acute cardiogenic pulmonary edema
![Page 31: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/31.jpg)
• DOSAGE :- 2 – 4 mg i.v, slowly - Goal = pain ( - )
• PRECAUTIONS :- hypotension- CNS/respiratory depression
![Page 32: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/32.jpg)
NITROGLYCERIN
• MECHANISME OF ACTION :Vasodilatation :- pre load, after load- coronary artery vasodilatation
• INDICATION :- ischemic chest pain- ongoing or recurrent ischaemia in MI- pulmonary edema, hypertensive urgency
![Page 33: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/33.jpg)
• DOSAGE :- i.v. = start with 10 – 20 mc/min- SL = 0,5 mg, repeat after 5 min
• PRECAUTIONS :- hypotension- headache
![Page 34: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/34.jpg)
ASPIRIN
• MECHANISM OF ACTION :- anti platelet aggregation- blocking production of tromboxane A2- decrease mortality caused by IMA- decrease reinfark risk
• INDICATION :- all patient with ACS
![Page 35: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/35.jpg)
• DOSAGE :- 160 – 320 mg PO- chewing
• PRECAUTIONS :- ulcus pepticum, asthma- hypersensitive
![Page 36: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/36.jpg)
FIBRINOLYTICS
• MECHANISME OF ACTION :reperfusion of myocardium
• INDICATION :- ST elevation MI or new LBBB- < 12 hr from onset
• CHOICE :- streptokinase
![Page 37: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/37.jpg)
• DOSAGE :streptokinase 1,5 million unit i.v. dilute in 100 cc, infused for 30 – 60 min
• PRECAUTION :- bleeding - allergy- hypotension - reperfusion arrhythmia
• CONTRA INDICATION :- history of haemorhage stroke- history of nonhaemorhage stroke in the past year- intra cranial tumor - active internal bleeding
![Page 38: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/38.jpg)
CALCIUM CHLORIDE
• INDICATION :- Hypo Ca- Hyper K- Ca channel blocker/-blocker overdose
• DOSAGE :5 – 10 ml 10% CaCl2
![Page 39: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/39.jpg)
SODIUM BICARBONATE
• INDICATION :- Hyper K- Tricyclic antidepressant overdose
• DOSAGE :- 1 mmol/Kg i.v. bolus- monitor BGA
• PRECAUTION :not routine for cardiac arrest
![Page 40: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/40.jpg)
PHARMACOLOGIC ALTERATIONSIN PREGNANCY
• metabolism and volume of distribution of drug
• increased plasma volume • changes in the blood consentration• Local anesthetic drugs induce fetal
acidosis • blocker capable of causing fetal
bradycardia
![Page 41: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/41.jpg)
• vasopressors can cause utero-placental vasoconstriction, with reduced fetal oxygenation & carbondioxide elimination
• sodium bicarbonate crosses the placental barrier
![Page 42: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/42.jpg)
![Page 43: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/43.jpg)
Guidelines for Resuscitation 2005
1. Main changes in adult basic life support
2. Main changes in automated external defibrillation
3. Main changes in adult advanced life support
4. Main changes in paediatric life support
![Page 44: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/44.jpg)
• unresponsive and not breathing
normally
• place the hands on the centre
of the chest
• 1 sec rather than 2 sec
• the ratio of compressions to ventilations is 30 : 2 • 30 compressions is being
given immediately (for adult)
• start CPR (….A-B-C etc)
• Using the rib margin method is wasting time
• each rescue breath over
1 sec
• for all adult, and children
( for a lay rescuer)
• the 2 initial rescue breaths are omitted
Main changes in adult basic life support
![Page 45: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/45.jpg)
Main changes in adult advanced life support
1. CPR before defibrilation2. Defibrilation strategy3. Fine VF4. Adrenaline ( epinephrine )
5. Anti-arrhythmic drugs6. Thrombolytic therapy for cardiac arrest7. Post resuscitation care – therapeutic hypothermia
![Page 46: 6.Cardiovascular Supporting Drugs](https://reader035.fdocuments.net/reader035/viewer/2022081604/563dba07550346aa9aa20ec0/html5/thumbnails/46.jpg)
CPR before defibrilation
• in out of hospital C A• unwitness cardiac arrest
• do not delay defibrilation
• Give CPR for 2 minutes
(30 : 2 )
• witnessed cardiac arrest